GSK - GSK Trades At Low Price Multiples But Its Pipeline Needs To Improve
2024-04-19 04:02:55 ET
Summary
- GSK trades at lower price multiples compared to competitors due to weaker pipeline.
- GSK's revenue growth in 2023 was modest, but it has strong performers in its product mix.
- GSK needs to demonstrate the effectiveness and efficiency of its pipeline to catch up to competitors.